investor day home
ep growth outlook impli compound-annual-growth-rate
yesterday host first investor day year provid preliminari adj
ep guidanc well detail outlook number in-lin
expect guidanc includ ca bill cut
estim also includ it- otherwis ep in-lin tone day
posit compani posit stori one solid underli oper
incom growth capit deploy stori compani posit
shift home dialysi posit margin return capit note
largest home dialysi censu home busi grow
in-cent growth rate addit compani see shift medicar
advantag clear posit appear take conserv view
contribut lower ep estim pass
california reiter buy rate given compani strength home
dialysi abil deploy capit benefit would better
expect
updat way guid replac op incom guidanc ep
move away per treatment metric toward margin redefin
includ capital-expenditure adj ep expect impli growth
midpoint expect revenu op incom
margin capital-expenditure yield adj
ep impli adjust revenu growth
ep compound-annual-growth-rate number gener line
expect speak lsd organ oper incom growth supplement
capit deploy drive double-digit ep
cali bill number ballot initi
note guidanc includ normal annual advocaci cost
includ potenti cost associ ballot initi spent
sinc hard predict occur everi year
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
davita inc lead dialysi provid
unit state compani oper
outpati clinic us serv
patient also oper countri
outsid us
sale davita medic group dmg
posit use bulk proce
share repurchas still pay debt
make increment invest
health care servic outsid dialysi
po base ebitda estim around midpoint
stand-alon histor rang ebitda dmg sale allow
focu core dialysi busi deploy capit
upsid risk po commerci mix better expect
reimburs better expect make chang third
downsid risk po commerci price pressur could continu
potenti commerci mix pressur manag care vast major dialysi
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
